医疗住院患者中便秘的流行,识别和危险因素:一个队列前性研究
Jawahar Al Nou'mani1, Abdullah M Al Alawi1,2, Juhaina Salim Al-Maqbali3,4
1Internal Medicine Residency Training Program, Oman Medical Specialty Board, Muscat 130, Oman.
Medicina (Kaunas, Lithuania)
|July 29, 2023
概括
便秘显著影响住院患者,影响超过一半的研究对象. 早期检测至关重要,因为医疗团队经常错过这种常见的胃肠道问题.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 便秘是一种常见的胃肠道疾病,对患者的生活质量和医疗保健成本产生重大影响.
- 它导致医疗访问,专家转诊和住院病人的增加,突出显示医疗机构需要更好的管理.
研究的目的:
- 确定通用医学病房的成年患者中便秘的患病率.
- 为了确定风险因素,评估识别率,并了解住院患者便秘的临床过程.
主要方法:
- 一项前性研究对556名成人患者进行,这些患者被录取到通用医学部门.
- 使用便秘评估量表 (CAS) 评估便秘,并从医疗记录中收集数据.
主要成果:
- 便秘的患病率为55.6%,年龄较大和脆弱性得分较高是显著因素.
- 独立的危险因素包括心力衰竭,虚弱以及使用二皮里丁通道阻塞剂.
- 在64.01%的受影响患者中,医疗团队无法识别便秘.
结论:
- 便秘在医疗住院患者中非常普遍,通常被医疗保健提供者忽视.
- 实施每日便秘评估尺度对于及时识别和治疗至关重要.
相关概念视频
Assessment of the Rectum and Anus
278
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
278
Irritable Bowel Syndrome III: Medical and Nursing Management
242
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
242
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
192
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
192
Assessment of the Gastrointestinal System II: Health Perception Pattern
141
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
141
Drugs for Treatment of Constipation-Predominant IBS
213
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
213


